Related references
Note: Only part of the references are listed.Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
Dhanasekhar Reddy et al.
FRONTIERS IN ONCOLOGY (2020)
Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes
Jacqueline Aredo et al.
LUNG CANCER (2019)
Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors
Shih-Chieh Chang et al.
TRANSLATIONAL ONCOLOGY (2019)
Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis
Yan Wang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
Fang Wang et al.
CANCER COMMUNICATIONS (2019)
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
Troels Dreier Christensen et al.
ACTA ONCOLOGICA (2018)
EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
Hong-Yang Lu et al.
ONCOTARGETS AND THERAPY (2018)
PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort
Kenji Sawa et al.
LUNG CANCER (2017)
LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer
Andrea Imperatori et al.
LUNG CANCER (2017)
PIK3CA mutations as prognostic factor in squamous cell lung carcinoma
Marc McGowan et al.
LUNG CANCER (2017)
The PI3K/AKT Pathway as a Target for Cancer Treatment
Ingrid A. Mayer et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma
Zhengbo Song et al.
CANCER MEDICINE (2016)
Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α
Ignacia Echeverria et al.
FEBS JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma
Yoshihito Iijima et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies
Matthias Scheffler et al.
ONCOTARGET (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
S. Li et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma
Joseph Thaddeus Beck et al.
CANCER TREATMENT REVIEWS (2014)
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
Thibault Vieira et al.
LUNG CANCER (2014)
PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
Lei Wang et al.
PLOS ONE (2014)
Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease
Luca Toschi et al.
PLOS ONE (2014)
PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
Lina Zhang et al.
ONCOTARGETS AND THERAPY (2013)
PIK3CA mutation in Chinese patients with lung squamous cell carcinoma
Jinglin Yu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2013)
Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
Hideki Yamaguchi et al.
JOURNAL OF CELL BIOLOGY (2011)
Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer
Vienna Ludovini et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
HEGESMA: genome search meta-analysis and heterogeneity testing
E Zintzaras et al.
BIOINFORMATICS (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Share Paper
